Get started

Rebound

FTSE CHINA A50 Possible Price Rebound?Price was within the descending channel for this equity index and lately, china had done very well combating the virus outbreak and it has lower death rate comparing to Italy and thousand have already been recovered where new cases weren't escalating the way it used to like past. This all proves that china is one of a great nation around the world which may prolly rise back first from this global pandemic chaos in the near future. It was the origin of that cruel virus and people have suffered a lot in the past which I believe the virus cases have reached its peak till today and nothing can get more worst if they continue holding this virus within the jar till the vaccine development. The easing of restrictions comes as Hubei reported that new infections dropped to zero on March 19. A dramatic plunge from the height of an epidemic that’s infected around 81,171 Chinese and killed over 3,277 but recovered 73,159 (which is a great achievement) on the date report 2020 March 24. China to lift lockdown over virus epicenter Wuhan on April 8 allowing transportation to resume for the city. All these positive changes in china let me feel that it may help domestic equities to run smoothly in the near weeks or months creating a rebound on the price action for this index. At least for short to mid-term even if it's not an overall reversal it may have probabilities to create new swing highs.
CLong
by jessi061
seems like this is a bottoming out process in place ??? All sign of a bottoming out process is there clear volume and uptrend in place since last week After the 2 trillions package agreed , we shall see a sharp rebound for good , forget about the fundamentals the market doesn't seem to let go of their big tech names , the drop has been subdue compared to European stocks back to 2009 levels and dj pr SP 500 Th upside seems much greater than the downside LET ME KNOW YOUR VIEWS
SWB:LYMSLong
by PhilippeDelpCFA
SPY-Short term Support/Resistance , AlphaOverBeta Market OutlookHello traders, The market had its first trade halt since 2008, and volatility is extremely high (more than 4 times the average), Trading the market is challenging. Our models have set two checkpoints for the market to make a short term decision: 270 - is the short term support for the S&P500, breaking that support would generate another leg to the downside 290 - is the short term resistance, breaking it to the upside would trigger a short term rally to the upside Remember to trade with rules, not emotions, the market will rebound, make sure you are in the game to benefit from it. Trade Smartly, Alon, AlphaOverBeta
AMEX:SPY
by Alon_AOB
EURNZD Bearish ToneI am feeling these pairs have some room lower to retracement watching over the sentiment. Bulls are getting exhausted aren't doing fine with upbeat and watching over the rising trendline and Fibonacci retracement level I assume there may have some pullback in this pair even if it won't be an overall reversal. Ya and hope you guys knew BOE just cut the rate by 50bp so be careful about the pound pairs and I also heard morning Chinese President Xi Jinping flew to the central city of Wuhan for a surprise visit, his first trip to the center of the epidemic since the health crisis erupted. His arrival in the virus-stricken city, which was locked down about a month-and-a-half ago, was a sign that conditions have improved so much that authorities deemed it safe for the country’s top leader to visit.
Short
by jessi061
1
2020: Canadian Energy Set to ReboundThe entire sector of energy has taken a beating over the last while and much of the sector remains incredibly undervalued; P/Bs in many cases are well below 1.5. In 2020 one of my top performing sector picks will be Canadian energy stocks, much moreso even than American energy stocks. The sector in Canada will be set to rebound from increasing oil prices and an increase in cap-x. In particular stocks like Canadian Res, Enbridge, Suncor, and TRP should boast some pretty good gains over the next 12 months as I believe oil will continue to tag along in this market and push to 70-80.00 a barrel as further cuts in Saudi Arabia will remain evident. I believe CNQ will finally break-out of its 10 year resistance level and quadruple peak and likely push 20% higher before 2021. Similarly, Suncor will likely do much the same. I am much more bullish on the Canadian energy sector rather than the US, and for those looking for cheap value stocks with continued CAGR, growth and likely at-least a 15% upside in 2020, you want to go with TRP and ENB for the pipelines and CNQ/SU for the production. - zSplit
TSX:CNQ
by PaulDeep19131
EURAUD Probabilities For Rebound?This is not a guarantee investment advice but seeing the potential risk to reward for upside and knowing the ECB head Lagarde due to give a speech in some minute I thought this pair will have some good volatility. Knowing that during the Asian session the latest updates on retail sales and trade balance for Australia were worst then forecast and previous but the pair continues its downtrend which was fishy and wasn't actually mean to be technically and fundamentally (kinda like things were already priced in). This time we can see a possible rebound from fib 61.80% and knowing if ECB head Lagarde has something good to say which may help boost the euro upward and if coronavirus weighs over higher-yielding currency like Aussie again will be plus point for bull traders in this pair.
Long
by jessi061
2
$VIVE Viveve Medical Inc Has Gaps To Fill$VIVE has come across our screen after the company received 510k approval of its Viveve System 2.0, which is its second generation product. This is a big development and explains why the stock is up 24% today. We believe there's a lot more room for $VIVE to run as there are gaps above that need to be filled. There's $1.50 to $1.84 and then $2.50 to $3.18 Furthermore, the risk/reward looks good. Can go Long here with a stop at new 52-week lows at $.41 a share. As always, trade with caution and use protective stops. Good luck to all! About Viveve Viveve Medical, Inc. is a medical technology company focused on women's intimate health. Viveve is committed to advancing new solutions to improve women's overall well-being and quality of life. The internationally patented Viveve® System incorporates cryogen-cooled monopolar radiofrequency (CMRF) technology to uniformly deliver volumetric heating while gently cooling surface tissue to generate neocollagenesis in a single in-office session. International regulatory approvals and clearances have been received for vaginal laxity and/or improvement in sexual function indications in over 50 countries. Viveve is conducting VIVEVE II, a multicenter, randomized, double-blind, sham-controlled clinical trial to assess improvement of sexual function in women following vaginal childbirth. Completion of full 250 subject enrollment was announced in early March 2019. If successful, VIVEVE II results could support a marketing application for a new U.S. commercial indication. Currently, in the United States, the Viveve® System is cleared by the FDA for use in general surgical procedures for electrocoagulation and hemostasis. Viveve has fully enrolled LIBERATE-International, one of two planned independent, multicenter, randomized registration trials for the improvement of stress urinary incontinence in women and plans to re-submit an IDE to the FDA for LIBERATE-U.S. after conducting certain safety testing. The results of these two trials, if successful, could support marketing applications in the U.S. and over 30 countries around the world for this new commercial indication.
VLong
by InsiderFinancial
Looking for a Nice Rebound to 31I think this stock will recover some of it's losses, regardless of the outcome of the potential FDA restrictions on drug suggestions. The stock has a solid business model and the company has said they are seeing increased demand. This new fields of genetics testing still needs to establish itself in the healthcare payer ecosystem, which presents some risk, but all in all I think the fundamentals are sound, making this a buying opportunity.
NASDAQ:MYGNLong
by intelitrades
$SNCR Synchronoss Technologies Has Room To Run and Gaps To Fill$SNCR has been one of the most beaten down names in the tech sector. The stock once traded as high as $52.50 a share before starting its long descent. Now, things look to be turning for the company and its stock. Roth Capital analyst Richard Baldry initiated coverage on the cloud-based enterprise computing and messaging specialist with a buy rating and a $13 price target. This follows the company's investor day where participants liked what they heard in terms of $SNCR longer-term growth, sales, and capital-allocation strategies. With all the gaps needed to be filled overhead and the depressed nature of the stock, we believe $SNCR can make a serious run higher. Shares are now trading above their 20, 50 and 200-day moving averages. It would not surprise us to see a quick move to the $10 to $12 region. As always, trade with caution and use protective stops. Good luck to all!
NASDAQ:SNCRLong
by InsiderFinancial
2